{"id":1021885,"date":"2026-11-17T14:02:49","date_gmt":"2026-11-17T19:02:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"modified":"2026-11-17T14:02:49","modified_gmt":"2026-11-17T19:02:49","slug":"freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","title":{"rendered":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BRISBANE, Calif., Nov.  17, 2026  (GLOBE NEWSWIRE) &#8212; <strong>Freenome, Inc. (NASDAQ: FRNM<\/strong>), a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests, today announced company management will participate in the Piper Sandler 38<sup>th <\/sup>Annual Healthcare Conference.<\/p>\n<p>Management will participate in a fireside chat from 4:30pm to 4:55pm Eastern Time on Tuesday, Dec. 1, 2026.<\/p>\n<p>A live and archived webcast of the events will be available on the \u201cEvents\u201d section of the Freenome investor relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x83zRxz2i7tVMeL-6MTnsHLGj6XqMI1ys6E6cEPvFbBeSGjYao0T4kd8DJ2udlNBrI2aC1FB3EyS4aNAY8nJv7HUKT8KIvh8M8nj94hxNV-VmCYwqHlErV9FCfyCp3tX0Ya5RELv45F8Wft5iQUI0uIfFZ-CZwixrXoMIb_zyMI=\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/investors.freenome.com\/news-events\/events<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Freenome<\/strong><\/p>\n<p>Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company\u2019s proprietary AI-driven multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome\u2019s development of FDA-approved SimpleScreen CRC for colorectal cancer screening and a pipeline of tests for lung cancer and additional single- and multi-cancer indications is designed to increase cancer screening participation among millions of at-risk individuals.<\/p>\n<p>\n        <strong>Freenome Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Gilmartin Group LLC<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>investor-relations@freenome.com<\/p>\n<p>\n        <strong><br \/>\n          <em>Media Contact<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Ryan Flinn<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>The Grace Group<br \/>ryan@gracegroup.us<br \/>media@gracegroup.us<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzE1ODM4Y2QtMzZmMi00MjYzLThlOGYtMTc5ZmE4MjY1N2Y0LTExOTM3MjItMjAyNi0xMS0xNy1lbg==\/tiny\/Freenome-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Freenome, Inc. (NASDAQ: FRNM), a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests, today announced company management will participate in the Piper Sandler 38th Annual Healthcare Conference. Management will participate in a fireside chat from 4:30pm to 4:55pm Eastern Time on Tuesday, Dec. 1, 2026. A live and archived webcast of the events will be available on the \u201cEvents\u201d section of the Freenome investor relations website at https:\/\/investors.freenome.com\/news-events\/events. About Freenome Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company\u2019s proprietary AI-driven multiomics discovery platform analyzes circulating cell-free DNA methylation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1021885","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Freenome, Inc. (NASDAQ: FRNM), a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests, today announced company management will participate in the Piper Sandler 38th Annual Healthcare Conference. Management will participate in a fireside chat from 4:30pm to 4:55pm Eastern Time on Tuesday, Dec. 1, 2026. A live and archived webcast of the events will be available on the \u201cEvents\u201d section of the Freenome investor relations website at https:\/\/investors.freenome.com\/news-events\/events. About Freenome Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company\u2019s proprietary AI-driven multiomics discovery platform analyzes circulating cell-free DNA methylation &hellip; Continue reading &quot;Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-17T19:02:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference\",\"datePublished\":\"2026-11-17T19:02:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"},\"wordCount\":202,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\",\"name\":\"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\",\"datePublished\":\"2026-11-17T19:02:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","og_description":"BRISBANE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Freenome, Inc. (NASDAQ: FRNM), a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests, today announced company management will participate in the Piper Sandler 38th Annual Healthcare Conference. Management will participate in a fireside chat from 4:30pm to 4:55pm Eastern Time on Tuesday, Dec. 1, 2026. A live and archived webcast of the events will be available on the \u201cEvents\u201d section of the Freenome investor relations website at https:\/\/investors.freenome.com\/news-events\/events. About Freenome Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company\u2019s proprietary AI-driven multiomics discovery platform analyzes circulating cell-free DNA methylation &hellip; Continue reading \"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-17T19:02:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference","datePublished":"2026-11-17T19:02:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"wordCount":202,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","name":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=","datePublished":"2026-11-17T19:02:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3OTExMyM3OTcwMTM4IzIxODIxNTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freenome-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1021885"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021885\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1021885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1021885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1021885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}